ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $514,000 | +65.8% | 85,322 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $310,000 | +33.6% | 86,042 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $232,000 | -9.7% | 86,639 | -0.1% | 0.00% | 0.0% |
| Q1 2019 | $257,000 | +81.0% | 86,708 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $142,000 | -57.2% | 89,518 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $332,000 | +32.3% | 90,206 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $251,000 | -22.0% | 88,582 | +2.2% | 0.00% | 0.0% |
| Q1 2018 | $322,000 | +41.9% | 86,667 | +9.9% | 0.00% | 0.0% |
| Q4 2017 | $227,000 | -35.5% | 78,827 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $352,000 | +5.7% | 78,454 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $333,000 | +9.5% | 72,588 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $304,000 | +9.4% | 72,153 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $278,000 | -99.9% | 67,382 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $547,204,000 | +4.0% | 67,556 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $526,133,000 | -2.2% | 67,453 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $538,000,000 | -28.0% | 69,629 | +0.5% | 0.00% | -33.3% |
| Q4 2015 | $747,000,000 | +156503.8% | 69,254 | +0.4% | 0.00% | +50.0% |
| Q3 2015 | $477,000 | -99.9% | 68,973 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $610,374,000 | -23.2% | 68,891 | -14.5% | 0.00% | -33.3% |
| Q1 2015 | $794,381,000 | +5.7% | 80,566 | +31.4% | 0.00% | 0.0% |
| Q4 2014 | $751,244,000 | +17.7% | 61,326 | -4.1% | 0.00% | 0.0% |
| Q3 2014 | $638,431,000 | +33.2% | 63,971 | +1.0% | 0.00% | +50.0% |
| Q2 2014 | $479,317,000 | +121.9% | 63,318 | -3.6% | 0.00% | +100.0% |
| Q1 2014 | $216,008,000 | +1.5% | 65,656 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $212,746,000 | +8.8% | 64,080 | -1.0% | 0.00% | 0.0% |
| Q3 2013 | $195,466,000 | -52.3% | 64,724 | +29.3% | 0.00% | -50.0% |
| Q2 2013 | $409,581,000 | – | 50,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |